氯胺酮联合咪达唑仑经鼻镇静用于儿童牙科治疗(NASO):随机对照试验研究方案
本研究为三臂平行随机对照试验,旨在评估氯胺酮联合咪达唑仑经鼻镇静用于2至6岁不合作儿童牙科治疗的有效性、安全性和成本效果。拟纳入84名儿童,随机分为经鼻氯胺酮(4.0 mg/kg,最大100 mg)联合咪达唑仑(0.2 mg/kg,最大5.0 mg)组、口服氯胺酮(4.0 mg/kg,最大100 mg)联合咪达唑仑(0.5 mg/kg,最大20 mg)组及口服咪达唑仑(1.0 mg/kg,最大20 mg)组,主要结局为基于数字视频观察量表评估的儿童行为。
要点
- 拟纳入84名2至6岁不合作且需修复性牙科治疗的儿童,随机分为三组。
- 主要结局为通过数字视频观察量表评估的儿童行为。
- 次要结局包括镇静接受度、术中事件记忆、应激、不良事件、疼痛、感知及经济分析。
核心结论
- 本研究将提供从不同结局角度检验镇静方案的数据,可实质性补充科学与儿童牙科领域。
研究设计与样本
- 三臂平行随机对照试验,在巴西一家牙科镇静中心招募2至6岁健康儿童。
- 样本量经对前30例进行盲法中期分析后估计为84名儿童。
关键数值与推荐
- A组:经鼻给予氯胺酮4.0 mg/kg(最大100 mg)和咪达唑仑0.2 mg/kg(最大5.0 mg)。
- B组:口服给予氯胺酮4.0 mg/kg(最大100 mg)和咪达唑仑0.5 mg/kg(最大20 mg)。
- C组:口服给予咪达唑仑1.0 mg/kg(最大20 mg)。
- 主要结局为通过观察量表使用镇静下修复性牙科治疗的数字视频评估儿童行为。
- 次要结局包括镇静给药接受度、术中事件记忆、儿童应激、不良事件、术中疼痛、家长、牙医和儿童对镇静的感知及经济分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Uncooperative children may need to receive dental treatment under sedation, which is indicated when nonpharmacological behavior guidance is unsuccessful. There are randomized controlled trials (RCTs) comparing different sedative protocols for dental procedures; however, the evidence for superiority of one form over another is weak. The primary aim of this study is to investigate the efficacy of intranasally administered ketamine plus midazolam for the dental treatment of children. METHODS: We have designed a three-armed, parallel RCT to assess intranasal sedation using ketamine/midazolam in terms of the following measures: efficacy, safety, and cost-effectiveness. Two- to 6-year-old healthy children, referred for dental treatment in a dental sedation center in Brazil due to uncooperative behavior and requiring restorative dental procedures, will be recruited. Each child will be randomly assigned to one of the three groups: A - Intranasal administration of ketamine (4.0 mg/kg, maximum 100 mg) and midazolam (0.2 mg/kg, maximum 5.0 mg); B - Oral administration of ketamine (4.0 mg/kg, maximum 100 mg) and midazolam (0.5 mg/kg, maximum 20 mg); and C - Oral administration of midazolam (1.0 mg/kg, maximum 20 mg). The primary outcome is the child's behavior assessed through an observational scale using digital videos of the restorative dental treatment under sedation. The secondary outcomes are as follows: acceptance of sedative administration; memory of intraoperative events; the child's stress; adverse events; the child's pain during the procedure; the parent's, dentists', and child's perceptions of sedation; and economic analysis. Measures will be taken at baseline and drug administration and during and after the dental procedure. The necessary sample size was estimated to be 84 children after a blinded interim analysis of the first 30 cases. DISCUSSION: This study will provide data that can substantially add to science and pediatric dentistry as it examines the effect of sedative regimes from different perspectives (outcomes). TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02447289 . Registered on 11 May 2015, named "Midazolam and Ketamine Effect Administered Through the Nose for Sedation of Children for Dental Treatment (NASO)."
引用
- Gomes HS, Miranda AR, Viana KA, et al. Intranasal sedation using ketamine and midazolam for pediatric dental treatment (NASO): study protocol for a randomized controlled trial. Trials. 2017. PMID: 28399933. doi:10.1186/s13063-017-1919-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。